Hypertension in patients with pheochromocytoma

Current Hypertension Reports

Volumn 1, Issue 6, 1999, Pages 540-545

  Hanna, Nader N ^a   Kenady, Daniel E ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; TUMOR MARKER;

ADRENAL TUMOR; ARTICLE; BLOOD; BLOOD PRESSURE; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERTENSION; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; PHYSIOLOGY; PROGNOSIS;

ADRENAL GLAND NEOPLASMS; BIOPSY, NEEDLE; BLOOD PRESSURE; CATECHOLAMINES; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTENSION; PHEOCHROMOCYTOMA; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033291090     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-996-0027-6     Document Type: Article

References (50)

1. Cook DM, Loriaux DL: The incidental adrenal mass Am J Med 1996, 101:88-94.
2. Tutuncu NB, Gedik O: Adrenal incidentaloma: report of 33 cases. J Surg Oncol 1999, 70:247-250.
3. Proye C, Jafari Manjili M, Combemale F, et al: Experience gained from operation of 103 adrenal incidentalomas. Arch Surg 1998, 383:330-333.
4. Caty MG, Coran AG, Geagen M, et al.: Current diagnosis and treatment of pheochromocytoma in children. Experience with 22 consecutive tumors in 14 patients. Arch Surg 1990, 125:978-981.
5. Stackpole RH, Melicow MM, Uson AC: Pheochromocytoma in children: report of nine cases and review of the first 100 published cases with follow up studies. J Pediatr 1963, 63:315.
6. Chen H, Doppman JL, Chrousos GP, et al.: Adrenocorticotropic hormone secreting pheochromocytomas: the exception to the rule. Surgery 1995, 118:988-995.
7. Herrera MF, Stone E, Deitel M, et al.: Pheochromocytoma producing multiple vasoactive peptides. Arch Surg 1992, 127:105-108
8. Werbel SS, Ober KP: Pheochromocytoma. Update on diagnosis, localization, and management. Med Clin North Am 1995, 79:131-153.
9. Brav EL, Tarazi RC, Fouad FM, et al.: Blood pressure regulation in pheochromocytoma. Hypertension 1982, 4(3 pt 2):193-199.
10. Brav EL. Pheochromocytoma: new concepts and future trends. Kidney Int 1991, 40:544-556.
11. Brav EL: Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 1994, 15:356-368.
12. Oishi S, Sato T: Plasma renin activity, aldosterone and catecholamines in phaeochromocytoma: effect of converting enzyme inhibition. J Hum Hyperten 1994, 8:923-924.
13. Plouin PF, Chatellier G, Rougeot MA, et al.: Plasma renin activity in phaeochromocytoma: effects of beta blockade and converting enzyme inhibition. J Hypertens 1988, 6:579-585.
14. Donckier JE, Michel LA, Collard E, et al.: Plasma atrial natriuretic factor and catecholamines before and during excision of pheochromocytoma. Acta Chir Belg 1991, 91:112-116.
15. Stepniakowski K, Januszewicz A, Lapinski M, et al.: Plasma atrial natriuretic peptide (ANP) concentration in patients with pheochromocytoma. Blood Press 1992, 1:157-161.
16. Kitamura K, Kangawa K, Kawamoto M, et al.: Adrenomedullin: a novel hypotensive peptide isolated from human pheochro mocytoma. Biochem Biophys Res Commun 1993, 192:553-560.
17. Nishikimi T, Kitamura K, Saito Y, et al.: Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994, 24:600-604.
18. Levenson JA, Safar ME, London GM, et al.: Haemodynamics in patients with phaeochromocytoma. Clin Sci 1980, 58:349-356.
19. Smithwick RH, Greer NER, Robertson CW, et al.: Pheochromocytoma; a discussion of symptoms, signs and procedures of diagnostic value. N Engl J Med 1950, 242:252-257.
20. Smithwick RH: The surgical physiology of hypertension. Surg Clin North Am 1949, 29:1699-1730.
21. Streeten DH, Anderson GH Jr: Mechanisms of orthostatic hypotension and tachycardia in patients with pheochro mocytoma. Am J Hypertens 1996, 9:760-769.
22. Crout JR, Sjoerdsma A: Turnover and metabolism of catecholamines in patients with pheochromocytoma. J Clin Invest 1964, 43:92-94.
23. Wocial B, Januszewicz W: Urinary excretion of catecholamines and their metabolites in patients with pheochromocytoma. Ann Endocrinol (Paris) 1974, 35:237-246.
24. Platts JK, Drew PJ, Harvey JN: Death from phaeochromocy toma: lessons from a postmortem survey. J R Coll Physicians Lond 1995, 29:299-306.
25. Sutton MG, Sheps SG, Lie JT: Prevalence of clinically unsuspected pheochromocytoma. Review of a 50 year autopsy series. Mayo Clin Proc 1981, 56:354-360.
26. O'Riordain DS, Young WF Jr, Grant CS, et al: Clinical spectrum and outcome of functional extra adrenal paraganglioma. World J Surg 1996, 20:916-22.
27. Carney JA: The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra adrenal paraganglioma: a five-year review. Medicine (Baltimore) 1983, 62:159-169.
28. Whalen RK, Althausen AF, Daniels GH: Extra-adrenal pheochromocytoma. J Urol 1992, 147:1-10.
29. Modigliani E, Vasen HM, Raue K, et al: Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group. J Intern Med 1995, 238:363-367.
30. Frank-Raue K, Kratt T, Hoppner W, et al: Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto oncogene. Eur J Endocrinol 1996, 135:222-225.
31. Lenders JW, Keiser HR, Goldstein DS, et al: Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med 1995, 123:101-109
32. Wocial B, Januszewicz W, Gryglas P, et al: Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma. Przegl Lek 1997, 54:793-798.
33. Stridsberg M, Husebye ES: Chromogranin A and chromogra nin B are sensitive circulating markers for pheochromocy toma. Eur J Endocrinol 1997, 136:67-73.
34. Sjoberg RJ, Simcic KJ, Kidd GS: The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. Arch Intern Med 1992, 152:1193-1197.
35. Grossman E, Goldstein DS, Hoffman A, et al: Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension 1991, 17(6 pt 1):733-741.
36. Jalil ND, Pattou FN, Combemale F, et al.: Effectiveness and limits of preoperative imaging studies for the localization of pheochromocytomas and paragangliomas: a review of 282 cases. Eur J Surg 1998, 164:23-28.
37. Graham DJ, McHenry CR: The adrenal incidentaloma: guidelines for evaluation and recommendations for management. Surg Oncol Clin North Am 1998, 7:749-764.
38. Roizen MF, Hunt TK, Beaupre PN, et al.: The effect of alphaadrenergic blockade on cardiac performance and tissue oxygen delivery during excision of pheochromocytoma. Surgery 1983, 94:941-945.
39. Boutros AR, Bravo EL, Zanettin G, et al.: Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med 1990, 57:613-617.
40. Perry RR, Keiser HR, Norton JA, et al.: Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg 1990, 212:621-628.
41. Furino A, Massagli C, Pesce CV, et al.: Clinical experience with alpha blockers and calcium antagonists in the perioperative treatment of pheochromocytoma. Minerva Anestesiol 1994, 60:719-723.
42. Colson P, Ryckwaert F, Ribstein J, et al.: Hemodynamic heterogeneity and treatment with the calcium channel blocker nicardipine during pheochromocytoma surgery Acta Anaesthesiol Scand 1998, 42:1114-1119.
43. Fernandez-Cruz L, Taura P, Saenz A, et al.: Laparoscopic approach to pheochromocytoma: hemodynamic changes and catecholamine secretion. World J Surg 1996, 20:762-768.
44. Joris JL, Hamoir EE, Hartstein GM, et al.: Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma. Anesth Analg 1999, 88:16-21.
45. Gagner M, Breton G, Pharand D, et al.: Is laparoscopic adrenalectomy indicated for pheochromocytomas? Surgery 1996, 120:1076-1080.
46. Gagner M, Pomp A, Heniford BT, et al.: Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg 1997, 226:238-247.
47. Godellas CV, Prinz RA: Surgical approach to adrenal neoplasms: laparoscopic versus open adrenalectomy. Surg Oncol Clin North Am 1998, 7:807-817.
48. Remine WH, Chong GC, Van Heerden JA, et al.: Current management of pheochromocytoma. Ann Surg 1974, 179:740-748.
49. Mahoney EM, Harrison JH: Malignant pheochromocytoma: clinical course and treatment. J Urol 1977, 118:225-229.
50. Pommier RF, Vetto JT, Billingsly K, et al.: Comparison of adrenal and extra-adrenal pheochromocytomas. Surgery 1993, 114:1160-1166.